Condition: Pancreatitis, Chronic · Pancreatitis, Acute · Pancreatic Duct Stones · Sponsor: Changhai Hospital
This study aims to determine whether combining aggressive intravenous hydration with indometacin is more effective at preventing pancreatitis after a Extracorporeal Shock Wave Lithotripsy (ESWL) than using indometacin alone. The study will involve patients who are scheduled to undergo ESWL for pancreatic stones. Participants will be randomly assigned to one of two groups: one will receive both the intravenous hydration and the rectal indometacin, while the other will receive only the rectal indometacin. The trial will be conducted at multiple centers, ensuring a broad and diverse patient population. The primary outcome of the study will be the incidence of pancreatitis after the ESWL procedure. This study is important because it could lead to a better understanding of how to prevent pancreatitis after ESWL, potentially improving patient outcomes and reducing the risk of serious complications.
This description comes directly from the study's public registry record.
Liang-Hao Hu · +8613817593520 · lianghao-hu@hotmail.com
Always discuss trial participation with your own doctor first.
| The Second Affiliated Hospital of Baotou Medical College | Baotou, China | Recruiting |
| Peking Union Medical College Hospital | Beijing, China | Recruiting |
| Hangzhou First People's Hospital | Hangzhou, China | Recruiting |
| The Third Xiangya Hospital of Central South University | Hunan, China | Recruiting |
| The First Hospital of Lanzhou University | Lanzhou, China | Not Yet Recruiting |
| Qilu Hospital of Shandong University | Shandong, China | Recruiting |
| Changhai Hospital | Shanghai, China | Recruiting |
| Ruijin Hospital | Shanghai, China | Recruiting |
| Shanghai Pudong New Area Gongli Hospital | Shanghai, China | Recruiting |
| Yunnan University Affiliated Hospital | Yunnan, China | Not Yet Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07202559